Indoco Remedies has announced its consolidated financial results for the quarter ending March 31, 2026, showcasing a significant rise in total income.
The company reported a 21.2% year-on-year (YoY) increase, bringing its total income to ₹475.57 crore, up from ₹392.23 crore in the same quarter last year.
In the March 2026 quarter, Indoco Remedies achieved a total income of ₹475.57 crore, marking a 21.2% YoY growth from ₹392.23 crore in the previous year.
The income also saw a 6.5% quarter-on-quarter (QoQ) increase from ₹446.34 crore in the December 2025 quarter.
This growth reflects the company's efforts to enhance its financial standing despite challenging market conditions.
Net loss for the March 2026 quarter narrowed to ₹23.68 crore, compared to a loss of ₹41.34 crore in the same period last year.
This improvement also represents a reduction from the ₹29.45 crore loss reported in the December 2025 quarter.
For the financial year ending March 31, 2026, Indoco Remedies reported a total income of ₹1,848.65 crore, reflecting a 10.7% YoY increase from ₹1,670.37 crore in the previous year.
However, the net loss for FY26 widened to ₹98.70 crore, compared to a loss of ₹77.95 crore in FY25.
The Board of Directors has recommended a dividend of ₹0.20 per equity share on the face value of ₹2 for the financial year 2025-2026, subject to approval at the upcoming 79th Annual General Meeting.
Read More: PB Fintech Share Price in Focus on Q4 FY26 Earnings Results: Net Profit up 53.9% YoY!
As of May 07, 2026, at 12:59 PM, Indoco Remedies share price on NSE was trading at ₹258.61 up by 13.09% from the previous closing price.
Indoco Remedies' financial results for the March 2026 quarter highlight a notable increase in total income and a narrowing of net losses. Despite a wider annual net loss, the company's quarterly performance indicates positive momentum in its financial recovery.
Want to track these market movements in Hindi? Visit Angel One News for daily updates and comprehensive share market news in Hindi.
Disclaimer: This blog has been written exclusively for educational purposes. The securities or companies mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks. Read all the related documents carefully before investing.
Published on: May 7, 2026, 1:20 PM IST
Team Angel One
We're Live on WhatsApp! Join our channel for market insights & updates
Get the link to download the App
